Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Insys Therapeutics, Inc. (INSY)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Inventory turnover | 0.8 | 1.1 | 0.8 | 0.8 | 0.9 | 1.2 | 1.1 | |
| Asset turnover | 0.3 | 0.4 | 0.7 | 1.2 | 1.4 | 1.7 | 0.8 | |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | -149.4% | -188.3% | 13.5% | 46.8% | 61.0% | 210.8% | | |
| ROIC (including intangibles) | -130.4% | -498.1% | 13.8% | 37.8% | 40.2% | 120.5% | -345.5% | 42.6% |
| ROE | 168.5% | -312.2% | 9.1% | 27.8% | 27.7% | 55.1% | 27.9% | 40.2% |
| ROA | -37.7% | -74.1% | 6.9% | 20.0% | 21.4% | 43.6% | -96.2% | -82.9% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 56.1 | 55.8 | 31.1 | 52.2 | 44.2 | 60.0 | 72.9 | |
| Days inventory outstanding | 290.8 | 307.8 | 293.4 | 527.7 | 562.3 | 418.7 | 339.5 | |
| Cash conversion cycle | 346.9 | 363.6 | 324.5 | 579.9 | 606.5 | 478.7 | 412.4 | |
|